Among retroviruses, lentiviruses such as HIV-1 display two distinct virological features: genomic hypervariation and infection of nondividing/terminally differentiated cells (i.e. macrophage). These traits contribute to viral evolution and pathogenesis, respectively. Our recent research suggests that these two unique virological characteristics of HIV-1 are mechanistically related and require a novel enzymatic property of the viral reverse transcriptase (RT): high binding affinity to dNTP substrates. During the previous funding period of this award, we identified a unique enzymatic property of HIV-1 RT, compared to MuLV RT. Indeed, we found that HIV-1 RT binds to the dNTP substrate with much higher affinity than MuLV RT. Interestingly, due to this unique dNTP binding property, HIV-1 RT efficiently catalyzes both DNA synthesis and mismatch extension (which contributes to its low enzyme fidelity), even at low dNTP concentration. We also found that two HIV-1 RT mutants with reduced dNTP binding affinity, V148I and Q151N, show reduced DNA synthesis efficiency at low dNTP concentrations and increased fidelity. Indeed, HIV-1 variants harboring these mutant RTs failed to infect macrophage containing low dNTP concentrations even though these viruses retain their ability to infect dividing cells containing high dNTP concentrations. In addition, due to their low dNTP binding affinity, these mutants display frequent stalling and elevated RNA template switching even at physiological dNTP concentrations. In fact, the Q151N mutant virus showed the highest viral recombination frequency among all RT mutants ever tested. The central hypothesis of this proposal is that the relatively high dNTP binding affinity of lentiviral RTs may be essential for two of the most important (and seemingly unrelated) features of the lentivirus family: their abilities to infect terminally differentiated cells and to undergo high rates of genomic mutation. First, we will perform a series of biochemical and virological experiments to elucidate the unique structural and mechanistic architecture of the HIV-1 RT active site, which is responsible for its high dNTP binding affinity. In this aim, both currently available HIV-1 RT mutants with altered dNTP binding affinity and in vivo HIV-1 RT variants that have been isolated from the HIV-1 infected patients will be employed. Second, we will test whether mutations of HIV-1 RT reducing dNTP binding affinity also reduces proviral DNA synthesis kinetics at low cellular dNTP concentrations, leading to loss of viral infectivity to macrophages. Third, we will test the effect of dNTP binding affinity of HIV-1 RT on the viral recombination frequency. This proposed work is expected to provide insight into the impact of HIV-1 RT on a range of key biological features of HIV- 1: cell tropism, genomic mutability, recombination and pathogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI049781-09
Application #
7992448
Study Section
AIDS Molecular and Cellular Biology Study Section (AMCB)
Program Officer
Ussery, Michael A
Project Start
2000-12-01
Project End
2012-03-31
Budget Start
2010-12-01
Budget End
2012-03-31
Support Year
9
Fiscal Year
2011
Total Cost
$337,479
Indirect Cost
Name
University of Rochester
Department
Microbiology/Immun/Virology
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Valle-Casuso, Jose Carlos; Allouch, Awatef; David, Annie et al. (2017) p21 Restricts HIV-1 in Monocyte-Derived Dendritic Cells through the Reduction of Deoxynucleoside Triphosphate Biosynthesis and Regulation of SAMHD1 Antiviral Activity. J Virol 91:
Hafez, A Y; Messinger, J E; McFadden, K et al. (2017) Limited nucleotide pools restrict Epstein-Barr virus-mediated B-cell immortalization. Oncogenesis 6:e349
Baldauf, Hanna-Mari; Stegmann, Lena; Schwarz, Sarah-Marie et al. (2017) Vpx overcomes a SAMHD1-independent block to HIV reverse transcription that is specific to resting CD4 T cells. Proc Natl Acad Sci U S A 114:2729-2734
White, Tommy E; Brandariz-Nuñez, Alberto; Martinez-Lopez, Alicia et al. (2017) A SAMHD1 mutation associated with Aicardi-Goutières syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type I interferon in humans. Hum Mutat 38:658-668
Bloch, Nicolin; Gläsker, Sabine; Sitaram, Poojitha et al. (2017) A Highly Active Isoform of Lentivirus Restriction Factor SAMHD1 in Mouse. J Biol Chem 292:1068-1080
Hollenbaugh, Joseph A; Shelton, Jadd; Tao, Sijia et al. (2017) Substrates and Inhibitors of SAMHD1. PLoS One 12:e0169052
Mlcochova, Petra; Sutherland, Katherine A; Watters, Sarah A et al. (2017) A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophages. EMBO J 36:604-616
Daddacha, Waaqo; Koyen, Allyson E; Bastien, Amanda J et al. (2017) SAMHD1 Promotes DNA End Resection to Facilitate DNA Repair by Homologous Recombination. Cell Rep 20:1921-1935
Hollenbaugh, Joseph A; Montero, Catherine; Schinazi, Raymond F et al. (2016) Metabolic profiling during HIV-1 and HIV-2 infection of primary human monocyte-derived macrophages. Virology 491:106-14
Wang, Feifei; St Gelais, Corine; de Silva, Suresh et al. (2016) Phosphorylation of mouse SAMHD1 regulates its restriction of human immunodeficiency virus type 1 infection, but not murine leukemia virus infection. Virology 487:273-84

Showing the most recent 10 out of 76 publications